Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- Hospital Universitario Madrid Sanchinarro
Madrid, Spain
- Ucla School of Medicine
Los Angeles, California, United States
- Sharp Memorial Hosptal
San Diego, California, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- University Cancer & Blood Center, Llc
Athens, Georgia, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Mar 2016
- Primary completion
- 15 May 2017
- Completion
- 5 May 2018
- Last update posted
- 26 Mar 2019
- Registered enrollment
- 10
- Registry id
- NCT02568046
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.